Ask most physicians when perimenopause begins and they will point to the menstrual cycle: irregular periods, shortened cycles, the first hints of hormonal flux. Ask most women and they will say the same. We have built an entire cultural narrative around the period as the harbinger. But for a significant number of women, perimenopause announces itself first at 3 a.m. Not with a hot flash. Not with missed bleeding. With waking up, completely, inexplicably, and repeatedly, in the dark.

These women come to us tired. They come with brain fog, with irritability, with weight that has shifted without explanation, with a vague sense that something is wrong that they cannot name. And we, their physicians, do what we were trained to do: We treat the symptoms in front of us. We prescribe sleep aids. We screen for depression. We tell them their labs are normal and their anxiety is understandable given their stage of life. We are not wrong, exactly. We are just not seeing the whole picture.

Sleep is the canary in the coal mine

Estrogen and progesterone are not only reproductive hormones. They are architects of sleep. Progesterone is GABAergic; it has direct sedating effects. Estrogen modulates serotonin and norepinephrine, stabilizes thermoregulation, and influences rapid eye movement (REM) architecture. When these hormones begin to fluctuate in perimenopause, years before the final menstrual period, sleep is often the first system to show the strain. The 3 a.m. awakening is not insomnia in the conventional sense. It is a hormonal signal.

And here is where the fragmentation of medicine becomes a clinical liability. The patient sees her gynecologist for her cycle. She sees her internist for her fatigue. If she is lucky, she sees a sleep specialist for her insomnia. No one is in the room where all three conversations happen simultaneously. No one is connecting the dots between her sleep disruption, her weight gain, her mood, and the decade of hormonal transition she has just entered.

The metabolic domino nobody talks about

Sleep disruption in perimenopause is not merely a quality-of-life issue. It is a metabolic accelerant. Poor sleep elevates cortisol, increases ghrelin, suppresses leptin, and drives insulin resistance. In perimenopausal women, who are already navigating a shift toward central adiposity driven by estrogen decline, disrupted sleep compounds the metabolic burden in ways that are measurable, meaningful, and almost entirely ignored in the standard of care.

We tell these women to eat less and move more. We miss that they are fighting their own biology at 3 a.m. What these women need is not a sleep aid and a referral to a dietitian. They need a clinician who understands that their insomnia, their weight, and their hormones are not three separate problems. They are one problem, seen from three angles.

What we can do differently starting now

We do not need to wait for medicine to reorganize itself around integrated care. We can shift our clinical thinking today. When a woman in her late 30s or 40s presents with new-onset sleep maintenance insomnia, especially early morning awakening, perimenopause should be on the differential, even if her cycles are regular.

• Ask about night sweats subtle enough that she dismisses them.
• Ask about mood changes in the luteal phase.
• Ask about weight shifts she cannot explain.
• When she comes in with unexplained weight gain and fatigue, ask about her sleep before you order another thyroid panel.

And when she tells you something is wrong but she cannot describe it, believe her. The 3 a.m. awakening is her body trying to tell you something. Our job is to finally learn how to listen.

Isabella Soreca is a psychiatrist, sleep medicine physician, and obesity medicine physician.